Biodelivery Sciences International reported $256.07M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 72.26M 7.32M
Adamas Pharmaceuticals ADMS:US 143.98M 6.67M
Agile Therapeutics AGRX:US $ 36.68M 15.6M
Alimera Sciences ALIM:US $ 60.06M 2.04M
Biocryst Pharmaceuticals BCRX:US $ 265.76M 11.52M
Biodelivery Sciences International BDSI:US $ 256.07M 5.74M
Cara Therapeutics CARA:US $ 225.09M 3.64M
Cti Biopharma CTIC:US $ 101.23M 23.74M
Daiichi Sankyo 4568:JP Y 2110729M 48259M
Depomed DEPO:US $ 299.3M 12.71M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Knight Therapeutics Inc GUD:CN C$ 1.04B 6.03M
Lannett LCI:US $ 690.87M 7.13M
Mannkind MNKD:US $ 238.21M 14.58M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Redhill Biopharma RDHL:US $ 203.67M 16.45M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B